Global Deglycyrrhizinated Licorice Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Deglycyrrhizinated Licorice Market Research Report 2024
Glycyrrhizin glycyrrhizinate (DGL) is a light yellow fine powder. It is pure natural compound extracted from glycyrrhizin with high sweetness (approximately 80-300 times the sweetness of sucrose).
According to Mr Accuracy reports’s new survey, global Deglycyrrhizinated Licorice market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Deglycyrrhizinated Licorice market research.
Key manufacturers engaged in the Deglycyrrhizinated Licorice industry include Gansu Fanzhi Pharmaceuticals, Enzymatic Therapy, Xi' an Dinuo Biotechnoloies, TIANSHAN Pharmaceuticals, Selco Wirkstoffe Vertriebs GmbH, Jiangsu Tiansheng Pharmaceutical, Tiansheng Pharmaceutical and Qinghai Lake Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Deglycyrrhizinated Licorice were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Deglycyrrhizinated Licorice market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Deglycyrrhizinated Licorice market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Gansu Fanzhi Pharmaceuticals
Enzymatic Therapy
Xi' an Dinuo Biotechnoloies
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Qinghai Lake Pharmaceuticals
Segment by Type
High Purity
Low Purity
Food Industry
Cosmetics
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Deglycyrrhizinated Licorice report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Deglycyrrhizinated Licorice market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Deglycyrrhizinated Licorice market research.
Key manufacturers engaged in the Deglycyrrhizinated Licorice industry include Gansu Fanzhi Pharmaceuticals, Enzymatic Therapy, Xi' an Dinuo Biotechnoloies, TIANSHAN Pharmaceuticals, Selco Wirkstoffe Vertriebs GmbH, Jiangsu Tiansheng Pharmaceutical, Tiansheng Pharmaceutical and Qinghai Lake Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Deglycyrrhizinated Licorice were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Deglycyrrhizinated Licorice market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Deglycyrrhizinated Licorice market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gansu Fanzhi Pharmaceuticals
Enzymatic Therapy
Xi' an Dinuo Biotechnoloies
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Qinghai Lake Pharmaceuticals
Segment by Type
High Purity
Low Purity
Segment by Application
Food Industry
Cosmetics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Deglycyrrhizinated Licorice report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source